Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB26FWQUU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,092
Award facts
- Contract value 100% obligated
- $11,092.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,092.18 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, making this a specialized pharmaceutical procurement for federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems worldwide. The parent IDC vehicle enables the company to fulfill pharmaceutical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, positioning this delivery order as part of a broader strategic medical supply chain supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FWQUU?
SPE2DB26FWQUU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FWQUU worth?
The government has obligated $11,092 on SPE2DB26FWQUU.
Is contract SPE2DB26FWQUU an order under another contract?
Yes. SPE2DB26FWQUU is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB26FWQUU competed?
The extent of competition for SPE2DB26FWQUU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award